New Clinical Trials Available
At Texas Retina Associates, our physicians remain actively involved in conducting research that will improve care for our patients, offering access to promising new retinal treatments through clinical trials. We recently opened
read moreFour New Clinical Trials Available at Texas Retina Associates
Our physicians remain committed to participating in ongoing retina research and providing our patients access to promising new treatment options through clinical trials. We recently opened four new clinical trials: Diabetic Macular
read moreTexas Retina Associates Celebrates Employees Who Have Contributed 25+ Years of Service
As a new year begins, we would like to take a moment to thank and congratulate 12 employees who have served Texas Retina Associates for 25 or more years: Laurie A. Griffis,
read moreThree Texas Retina Associates Physicians Earn Honor Awards at American Society of Retina Specialists 2021 Annual Meeting
The American Society of Retina Specialists (ASRS) named Deborah Y. Chong, MD, and Robert C. Wang, MD, “Honor Awardees” at the organization’s 2021 Annual Scientific Meeting held recently in San Antonio. They
read moreDr. Coors and Dr. Christopher Fuller Served as Invited Faculty for Retina LIVE! Surgical Case Series Event
Texas Retina Associates’ Lori E. Coors, MD, and Christopher G. Fuller, MD, joined speakers from Bascom Palmer Eye Institute, Stanford University’s Byers Eye Institute, and Duke University Eye Center as part of
read moreDr. Wang’s Research Published in British Journal of Ophthalmology
Texas Retina Associates’ Robert C. Wang, MD, co-authored an article titled “Extension Study of the Safety and Efficacy of CLS-TA for Treatment of Macular Edema Associated with Non-infectious Uveitis (MAGNOLIA)” in the
read moreDr. Wang to Speak About Iritis at RheumNow Live! Event
Texas Retina Associates’ Robert C. Wang, MD, will give a presentation on “Iritis and HLA-B27” at the RheumNow Live! event this Sunday, March 21, 2021. RheumNow Live! is an on-site and virtual
read moreDr. Wang Co-authored Article on New Non-infectious Uveitis Treatment Published in Acta Ophthalmologica Journal
Texas Retina Associates’ Robert C. Wang, MD, co-authored an article titled “Management of Repository Corticotropin Injection Therapy for Non‐infectious Uveitis: A Delphi Study” in the March 2021 issue of the medical journal
read moreNew Clinical Trials Enrolling in Plano
At Texas Retina Associates, we remain committed to examining new options that are ethical, based on a solid science platform and provide minimal risks to our patients. Our Plano research team is
read more